Compare Fabrinet (FN) vs Teladoc Health Inc (TDOC) Price & Performance

Fabrinet (FN) trades at $487.33, down 2.14% on the day, amid a mixed technical backdrop with a bullish moving average signal but overbought RSI readings. Fundamentally, the company demonstrates strong profitability with a 10.19% net income margin and 21.33% ROE, supported by consecutive quarterly EPS beats. Recent news highlights surging AI data center demand driving revenue growth, though the stock faces pressure from high capital expenditures and customer concentration concerns.

The outlook remains positive given robust analyst sentiment (75% buy ratings) and a consensus price target of $769.50, implying significant upside. Key opportunities include capacity expansion to capture AI infrastructure growth, while risks involve margin compression from spending and reliance on a few hyperscaler customers. Earnings acceleration and market positioning support a constructive view, but volatility may persist near-term.

Teladoc Health (TDOC) trades at $5.54, down 0.36% on the day, as the stock faces bearish technical momentum despite recent earnings beats. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net income margin in 2026. Analyst sentiment is mixed with 35.7% buy ratings but a consensus price target of $8.83 suggesting 59% upside potential. Recent CFO appointment and legal officer transitions signal management changes amid ongoing operational challenges.

TDOC presents a high-risk opportunity with significant valuation discount (P/S 0.4x) but faces persistent profitability challenges. The integrated care business shows promise with improving margins, while BetterHelp weakness and negative cash flow in 2025 raise concerns. Upside depends on successful execution of turnaround strategy and achieving sustainable profitability in the competitive telehealth market.